期刊文献+

丙种球蛋白致川崎病患儿严重溶血性贫血1例并文献复习

A case report of severe haemolytic anaemia in patients with Kawasaki disease induced by intravenous immunoglobulin injection and literature review
原文传递
导出
摘要 报道1例丙种球蛋白致川崎病严重溶血性贫血的病例。患儿,女,7月龄,因“发热5 d,皮疹1 d”收入院。入院后患儿被诊断为川崎病,在应用累计剂量4 g·kg-1丙种球蛋白后,发生了丙种球蛋白致严重溶血性贫血的不良反应,予以甲泼尼龙治疗9 d,口服泼尼松片治疗3周,停药后3月随访无复发。以“川崎病(Kawasaki disease)”和“溶血性贫血(hemolytic anemia)”或“溶血(hemolysis)”为关键词在国内外数据库中检索文献(发表时间为1990年1月至2021年8月),共检索到符合条件的文献11篇,报道了42例丙种球蛋白致川崎病严重溶血性贫血的患儿,年龄2个月~16岁,其中94.4%患儿表现为直接抗人球蛋白试验阳性,66.7%患儿应用丙种球蛋白累计剂量4 g·kg^(-1),93.8%患儿为非O型血者。19例接受了输血治疗,9例接受了激素治疗。41例患儿治疗后恢复良好,1例患儿因合并嗜血细胞综合征和多系统功能衰竭死亡。
作者 厉青 张旭 LI Qing;ZHANG Xu
出处 《中国临床药学杂志》 CAS 2022年第1期67-70,共4页 Chinese Journal of Clinical Pharmacy
基金 浙江省嘉兴市公益性研究计划项目(编号2021AD30080)。
  • 相关文献

参考文献5

二级参考文献36

  • 1Bunin N J, Carev JL, Sullivan DB. Autoimmune hemolytic anemia in association with Kawasaki disease [ J ]. Am J Pediatr Hematol Onco1,1986,8(4) :351-353.
  • 2Panzarino V, Estrada J, Benson K,et al. Autoimmune hemolytic anemia after Kawasaki disease in a child [J]. Int J Hematol, 1993,57 (3) :259-263.
  • 3Berard R, Whittemore B, Scuccimarri R. Hemolytic anemia following intravenous immunoglobulin therapy in patients treated for Kawasaki disease : a report of 4 cases [ J ]. Pediatr Rheumatol Online J ,2012,16,10 ( 1 ) : 10. DOI : 10.1186/1546-0096-10-10.
  • 4Comenzo RL, Malachowski ME, Meissner HC, et al. Immune hemolysis, disseminated intravascular coagulation, and serum sickness after large doses of immune globulin given intravenously for Kawasaki disease[ J ]. J Pediatr, 1992,120 (6) :926-928.
  • 5Kahwaji J, Barker E, Pepkowitz S, et al. Acute hemolysis after high-dose intravenous imnarnoglobulin therapy in highly HLA sensitized patients [ J ]. Clin J Am Soc Nephrol, 2009,4 ( 12 ) : 1993-1997. DOI: 10. 2215/CJN. 04540709.
  • 6Dierickx D, Kentos A, Delannoy A. The role of rituximab in adults with warm antibody autoimmune hemolytic anemia [ J ].Blood, 2015, 125 (21) :3223-3229. DOI: 10. 1182/blood-2015- 01-588392.
  • 7Dierickx D, Beke E, Devos T, et al. The use of monoelonal antibodies in immune-mediated hematologic disorders [ J ]. Med ClinNorth Am, 2012, 96(3) :583-619, xi. DOI:10. 1016/j. mcna. 2012.04. 006.
  • 8Barcellini W, Zaja F, Zaninoni A, et al. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia [Jl. Eur J Haematol, 2013, 91 (6):546-551. DOI: 10. 1111/ ejh. 12199.
  • 9Berentsen S, Randen U, Tjcnnfjord GE. Cold agglutinin-mediated autoimmune hemolytic anemia[ J]. Hematol Oncol Clin North Am, 2015, 29 ( 3 ) :455-471. DOI : 10. 1016/j. hoc. 2015.01. 002.
  • 10Birgens H, Frederiksen H, Hasselbalch HC, et al. A phase Ⅲ randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia [ J ]. Br J Haematol, 2013, 163 ( 3 ) : 393-399. DOI:10.111/bjh. 12541.

共引文献152

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部